Proof of Mechanism Study for the Treatment of Social Anhedonia in ASD (ACEP4)
Proof of Mecahism Study for the Treatment of Social Anhedonia in ASD
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
This PHASE2 trial investigates ASD and is currently ongoing. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Jun 2025 — Present [monthly]
Unknown PHASE2
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Jun 2025 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Jul 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Nov 2022 — Jul 2023 [monthly]
Recruiting PHASE2
▶ Show 6 earlier versions
-
Jun 2022 — Nov 2022 [monthly]
Recruiting PHASE2
-
Jan 2021 — Jun 2022 [monthly]
Recruiting PHASE2
-
May 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Feb 2019 — May 2020 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Not Yet Recruiting PHASE2
-
Aug 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Jun 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .